| Dr Elizabeth A Blanchard, MD | |
|
1125 Madison St, Jefferson City, MO 65101-5227 | |
| (573) 632-5510 | |
| (573) 632-5810 |
| Full Name | Dr Elizabeth A Blanchard |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 38 Years |
| Location | 1125 Madison St, Jefferson City, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912900085 | NPI | - | NPPES |
| 04235109 | Other | MO | BNDD |
| 202424818 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | R9G99 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Capital Region Medical Center | Jefferson city, MO | Hospital |
| Ssm Health St Mary's Hospital Jefferson City | Jefferson city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Region Medical Center | 4688573686 | 168 |
| The Curators Of The University Of Missouri | 4486759560 | 959 |
News Archive
Banner Pharmacaps Inc. has confirmed that its Abbreviated New Drug Application for Bexarotene 75 mg soft gelatin capsules, a generic version of Targretin, has been accepted for review by the US Food and Drug Administration.
Worcester Polytechnic Institute researcher Kristen Billiar has been awarded a $154,000 grant from the American Heart Association to determine how cell death leads to calcium deposits in heart tissue that cause aortic valves to fail.
Researchers at MIT, the Broad Institute and Rockefeller University have developed a new technique for precisely altering the genomes of living cells by adding or deleting genes.
Researchers have found what appears to be a major culprit behind the loss of insulin-producing beta cells from the pancreases of people with diabetes, a critical event in the progression of the disease.
Castration-resistant prostate cancer (CRPC), defined as tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Current treatment regimens are complicated by toxicities and a low rate of relapse-free survival. Many novel therapies in clinical trials offer hope for patients with this challenging diagnosis. Healthcare professionals who are treating CRPC must stay abreast of these emerging therapies to ensure optimal care for these patients.
› Verified 9 days ago
| Entity Name | Capital Region Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477980837 PECOS PAC ID: 4688573686 Enrollment ID: O20070323000507 |
News Archive
Banner Pharmacaps Inc. has confirmed that its Abbreviated New Drug Application for Bexarotene 75 mg soft gelatin capsules, a generic version of Targretin, has been accepted for review by the US Food and Drug Administration.
Worcester Polytechnic Institute researcher Kristen Billiar has been awarded a $154,000 grant from the American Heart Association to determine how cell death leads to calcium deposits in heart tissue that cause aortic valves to fail.
Researchers at MIT, the Broad Institute and Rockefeller University have developed a new technique for precisely altering the genomes of living cells by adding or deleting genes.
Researchers have found what appears to be a major culprit behind the loss of insulin-producing beta cells from the pancreases of people with diabetes, a critical event in the progression of the disease.
Castration-resistant prostate cancer (CRPC), defined as tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Current treatment regimens are complicated by toxicities and a low rate of relapse-free survival. Many novel therapies in clinical trials offer hope for patients with this challenging diagnosis. Healthcare professionals who are treating CRPC must stay abreast of these emerging therapies to ensure optimal care for these patients.
› Verified 9 days ago
| Entity Name | The Curators Of The University Of Missouri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235126921 PECOS PAC ID: 4486759560 Enrollment ID: O20070418000290 |
News Archive
Banner Pharmacaps Inc. has confirmed that its Abbreviated New Drug Application for Bexarotene 75 mg soft gelatin capsules, a generic version of Targretin, has been accepted for review by the US Food and Drug Administration.
Worcester Polytechnic Institute researcher Kristen Billiar has been awarded a $154,000 grant from the American Heart Association to determine how cell death leads to calcium deposits in heart tissue that cause aortic valves to fail.
Researchers at MIT, the Broad Institute and Rockefeller University have developed a new technique for precisely altering the genomes of living cells by adding or deleting genes.
Researchers have found what appears to be a major culprit behind the loss of insulin-producing beta cells from the pancreases of people with diabetes, a critical event in the progression of the disease.
Castration-resistant prostate cancer (CRPC), defined as tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Current treatment regimens are complicated by toxicities and a low rate of relapse-free survival. Many novel therapies in clinical trials offer hope for patients with this challenging diagnosis. Healthcare professionals who are treating CRPC must stay abreast of these emerging therapies to ensure optimal care for these patients.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth A Blanchard, MD 1125 Madison St, Jefferson City, MO 65101-5227 Ph: (573) 632-5510 | Dr Elizabeth A Blanchard, MD 1125 Madison St, Jefferson City, MO 65101-5227 Ph: (573) 632-5510 |
News Archive
Banner Pharmacaps Inc. has confirmed that its Abbreviated New Drug Application for Bexarotene 75 mg soft gelatin capsules, a generic version of Targretin, has been accepted for review by the US Food and Drug Administration.
Worcester Polytechnic Institute researcher Kristen Billiar has been awarded a $154,000 grant from the American Heart Association to determine how cell death leads to calcium deposits in heart tissue that cause aortic valves to fail.
Researchers at MIT, the Broad Institute and Rockefeller University have developed a new technique for precisely altering the genomes of living cells by adding or deleting genes.
Researchers have found what appears to be a major culprit behind the loss of insulin-producing beta cells from the pancreases of people with diabetes, a critical event in the progression of the disease.
Castration-resistant prostate cancer (CRPC), defined as tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Current treatment regimens are complicated by toxicities and a low rate of relapse-free survival. Many novel therapies in clinical trials offer hope for patients with this challenging diagnosis. Healthcare professionals who are treating CRPC must stay abreast of these emerging therapies to ensure optimal care for these patients.
› Verified 9 days ago
Amanda Taube Rodemann, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Suite 102, Jefferson City, MO 65109 Phone: 573-636-5248 Fax: 573-636-9390 | |
Dr. William H. Marshall, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-635-5264 Fax: 573-556-5757 | |
Jodi A Berendzen, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Suite 102, Jefferson City, MO 65109 Phone: 573-636-5248 Fax: 573-636-9390 | |
Teri A Deffenbaugh, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1125 Madison St, Ob Gyn Associates, Jefferson City, MO 65101 Phone: 573-632-5510 Fax: 573-632-5810 | |
Serese Yvonne Smith-haxton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1125 Madison St, Jefferson City, MO 65101 Phone: 573-632-5510 Fax: 573-632-5810 | |
Brandi Nichols, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-636-5248 Fax: 573-636-9390 | |
Dr. Philo S Su, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2712 Plaza Dr, Jefferson City, MO 65109 Phone: 573-893-5500 |